PTAD-Derivatized Vitamin D Metabolite Detection for D2/D3 Resolution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring vitamin D metabolites in clinical settings lack the ability to separately resolve 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3, making it difficult to determine the source of nutritional deficiencies and requiring additional tests, while existing mass spectrometry methods often require derivatization or do not provide accurate bioactivity and bioavailability differences between these forms.
Innovation Solution
The use of mass spectrometry, specifically tandem mass spectrometry, with derivatization using Cookson-type reagents such as 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) to generate derivatized vitamin D metabolites, which are then subjected to extraction and analytical chromatography, allowing for the detection and quantification of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 without the need for additional tests.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If radioimmunoassay with antibodies co-specific for 25OHD2 and 25OHD3 is used, then measurement of vitamin D metabolites is achieved, but the ability to separately resolve 25OHD2 and 25OHD3 is lost
Solution Approach 1:
The patent segments the detection process by using derivatization chemistry that produces distinct mass spectral signatures for 25OHD2 and 25OHD3. The Cookson-type reagent reacts with the hydroxyl group at C25, creating derivatives with different mass-to-charge ratios that can be separately detected by mass spectrometry, thereby resolving the two metabolites without requiring complex multi-step procedures
Solution Approach 2:
The patent introduces derivatization reagents (Cookson-type reagents) as intermediaries that facilitate the separation and detection of 25OHD2 and 25OHD3. These reagents chemically modify the metabolites to produce detectable differences in mass spectrometry, serving as a mediator between the sample and the detection system
2Measurement precision
If existing mass spectrometry methods without derivatization are used, then measurement simplicity is maintained, but accurate differentiation and quantification of 25OHD2 and 25OHD3 is compromised
Solution Approach 1:
The patent changes the chemical parameters of the vitamin D metabolites through derivatization, modifying their mass-to-charge ratios and other detectable properties. This chemical transformation enables mass spectrometry to accurately differentiate between 25OHD2 and 25OHD3 by creating distinct spectral signatures that are easily distinguishable
3Measurement precision
If derivatization with Cookson-type reagents is performed, then separate detection of 25OHD2 and 25OHD3 is achieved, but additional processing steps are required
Solution Approach 1:
The patent performs derivatization as a preliminary action before mass spectrometry analysis. By chemically modifying the metabolites with Cookson-type reagents in advance, the method prepares the sample for efficient and accurate detection, separating the complex chemical modification step from the rapid analytical detection step
4Productivity
If high-throughput assay system is implemented, then productivity is improved, but measurement precision may be compromised
Solution Approach 1:
The patent replaces manual, time-consuming separation and detection procedures with automated mass spectrometry-based analysis. The derivatized metabolites are directly analyzed by mass spectrometry, which automatically quantifies 25OHD2 and 25OHD3 based on their distinct mass spectral signatures, enabling high-throughput processing without sacrificing precision
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables accurate and separate detection of vitamin D metabolites, providing a high-throughput assay system for clinical laboratories, allowing for precise quantification and differentiation between 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3, improving diagnostic capabilities and understanding of vitamin D nutritional status and bioactivity.
Implementation Method 1
The methods include derivatizing vitamin D metabolites in the sample prior to analysis
Implementation Method 2
subjecting one or more PTAD-derivatized vitamin D metabolites in the sample to an ionization source to generate one or more ions detectable by mass spectrometry
Implementation Method 3
determining the amount of one or more of the PTAD-derivatized vitamin D metabolite ions by mass spectrometry
Data Source
AI summary
The invention relates to the detection of vitamin D metabolites. In a particular aspect, the invention relates to methods for detecting derivatized vitamin D metabolites by mass spectrometry.